Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Insulet's Business Segments
Insulet's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 762
Regions Reported
1
Revenue Share by Region -
- Non-US31.9%
Revenue by Geographic Region -
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 243 | 31.9% |
Revenue by Product & Service Category -
- Product, Omnipod99.6%
- U.S. Omnipod67.7%
- International Omnipod31.9%
- Drug Delivery0.4%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product, Omnipod | $ 758 | 99.6% |
| U.S. Omnipod | $ 516 | 67.7% |
| International Omnipod | $ 243 | 31.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Insulet
Insulet Corporation is a medical technology company that was founded in 2000 and is headquartered in Acton, Massachusetts. The company specializes in developing and manufacturing insulin delivery systems for people with diabetes.
One of Insulet Corporation's main products is the Omnipod insulin management system, which is a tubeless, wearable insulin pump that delivers continuous insulin for people with Type 1 diabetes. The Omnipod system consists of two components: a pod that is worn on the body and a handheld device that is used to control the pod.
The Omnipod system is unique in that it is wireless and completely tubeless, making it more discreet and flexible than other insulin pumps on the market. The system also uses a proprietary algorithm that adjusts insulin delivery based on a user's glucose levels in real-time, making it more precise and effective for managing diabetes.
In addition to the Omnipod system, Insulet Corporation also offers a range of accessories and supplies to help people with diabetes manage their insulin therapy. These include test strips, lancets, and glucose meters.
Insulet Corporation is committed to innovation and is constantly developing new products and technologies to improve the lives of people with diabetes. The company has a team of engineers, scientists, and healthcare professionals who work together to research, develop, and bring new products to market.
Overall, Insulet Corporation is a leading medical technology company that is dedicated to helping people with diabetes manage their condition more effectively and efficiently. Their innovative products and commitment to patient care have made them a trusted name in the diabetes community.
One of Insulet Corporation's main products is the Omnipod insulin management system, which is a tubeless, wearable insulin pump that delivers continuous insulin for people with Type 1 diabetes. The Omnipod system consists of two components: a pod that is worn on the body and a handheld device that is used to control the pod.
The Omnipod system is unique in that it is wireless and completely tubeless, making it more discreet and flexible than other insulin pumps on the market. The system also uses a proprietary algorithm that adjusts insulin delivery based on a user's glucose levels in real-time, making it more precise and effective for managing diabetes.
In addition to the Omnipod system, Insulet Corporation also offers a range of accessories and supplies to help people with diabetes manage their insulin therapy. These include test strips, lancets, and glucose meters.
Insulet Corporation is committed to innovation and is constantly developing new products and technologies to improve the lives of people with diabetes. The company has a team of engineers, scientists, and healthcare professionals who work together to research, develop, and bring new products to market.
Overall, Insulet Corporation is a leading medical technology company that is dedicated to helping people with diabetes manage their condition more effectively and efficiently. Their innovative products and commitment to patient care have made them a trusted name in the diabetes community.
Insulet Corporation is a prominent medical device and technology company that focuses on enhancing diabetes management through innovative and convenient products and services. Its flagship product, the Omnipod Insulin Management System, positions the company as a leader in diabetes care. Below is an extensive overview of Insulets segments, products, and services:
Segments
Insulet Corporation operates across three primary geographical segments: North America, Europe, and the Asia-Pacific region. Each segment plays a crucial role in delivering diabetes management solutions worldwide:
1. Insulin Delivery:
- This segment focuses on the development and commercialization of insulin delivery systems that provide people living with diabetes an efficient and user-friendly method of insulin administration. The Omnipod Insulin Management System is at the heart of this segment, offering a tubeless insulin delivery system designed to enhance the quality of life for patients. This segment is the largest contributor to Insulet’s overall revenue and reflects the company’s commitment to diabetes care.
2. Non-Insulin Delivery:
- Insulet is expanding its capabilities beyond diabetes management with this segment. The focus is on drug delivery devices that cater to various therapeutic areas, including oncology, endocrinology, and neurology. This segment highlights Insulet’s innovation in developing advanced medical devices that meet diverse healthcare needs, thus diversifying their product offerings and reducing the companys dependence on diabetes products alone.
3. Development and Operations:
- This segment encompasses Insulets capabilities in clinical research, regulatory affairs, and manufacturing operations. It supports both the internal development of new products and offers external commercialization services. The focus here is on the systematic approach to product development that includes ensuring compliance with regulatory requirements, optimizing manufacturing processes, and advancing medical device innovation.
Products
Insulet Corporations product portfolio is centered around comprehensive diabetes management for individuals with type 1 and type 2 diabetes. The flagship product is the Omnipod Insulin Management System, which is designed to improve lifestyle flexibility for users. Key products include:
1. Omnipod Insulin Management System:
- This system consists of a tubeless insulin pump that is worn discreetly on the body. Users can administer insulin without the limitations posed by traditional tubing systems. The system is controlled via a wireless personal diabetes manager that allows for easy insulin dose adjustments.
2. Omnipod DASH:
- The latest iteration of the Omnipod system, DASH, enhances the user experience with an intuitive design, featuring a color touchscreen interface, extended wear time, and simplified menu navigation. It facilitates better diabetes management by providing a seamless connection between the insulin pump and the user.
3. Omnipod VIEW:
- This data management software is designed to give users a clear view of their insulin delivery patterns and blood glucose levels. It helps users analyze their data, enabling more informed decision-making regarding their diabetes management strategies.
4. Omnipod DISPLAY:
- This mobile application allows users to control their Omnipod systems from their smartphones, making it easier to manage diabetes on the go. The app provides convenience and flexibility for users by enabling remote delivery adjustments.
Services
In addition to cutting-edge products, Insulet Corporation provides a suite of services aimed at supporting diabetes management and product innovation. These services include:
1. Clinical Research:
- Insulet conducts clinical trials to facilitate the development and therapeutic validation of its innovative diabetes management products. This research is crucial for ensuring the safety and efficacy of their devices.
2. Regulatory Services:
- The company offers regulatory consulting services, which assist in navigating the complex landscape of medical device regulations globally, ensuring that products meet safety standards and are compliant with regulatory requirements.
3. Manufacturing Operations:
- Insulet also offers contract manufacturing services for other medical device and drug delivery companies, leveraging its expertise in manufacturing complex medical devices and ensuring high-quality production standards.
4. Customer Support:
- Insulet is committed to providing robust customer support services, which include 24/7 availability to address inquiries and technical issues related to the Omnipod Insulin Management System. This support is essential for enhancing user experience and safety, particularly for individuals who manage diabetes daily.
In conclusion, Insulet Corporation offers a broad array of products and services tailored to meet the needs of individuals living with diabetes. By maintaining a focus on innovation, convenience, and comprehensive support, Insulet continues to strengthen its position as an industry leader in diabetes management solutions.
Segments
Insulet Corporation operates across three primary geographical segments: North America, Europe, and the Asia-Pacific region. Each segment plays a crucial role in delivering diabetes management solutions worldwide:
1. Insulin Delivery:
- This segment focuses on the development and commercialization of insulin delivery systems that provide people living with diabetes an efficient and user-friendly method of insulin administration. The Omnipod Insulin Management System is at the heart of this segment, offering a tubeless insulin delivery system designed to enhance the quality of life for patients. This segment is the largest contributor to Insulet’s overall revenue and reflects the company’s commitment to diabetes care.
2. Non-Insulin Delivery:
- Insulet is expanding its capabilities beyond diabetes management with this segment. The focus is on drug delivery devices that cater to various therapeutic areas, including oncology, endocrinology, and neurology. This segment highlights Insulet’s innovation in developing advanced medical devices that meet diverse healthcare needs, thus diversifying their product offerings and reducing the companys dependence on diabetes products alone.
3. Development and Operations:
- This segment encompasses Insulets capabilities in clinical research, regulatory affairs, and manufacturing operations. It supports both the internal development of new products and offers external commercialization services. The focus here is on the systematic approach to product development that includes ensuring compliance with regulatory requirements, optimizing manufacturing processes, and advancing medical device innovation.
Products
Insulet Corporations product portfolio is centered around comprehensive diabetes management for individuals with type 1 and type 2 diabetes. The flagship product is the Omnipod Insulin Management System, which is designed to improve lifestyle flexibility for users. Key products include:
1. Omnipod Insulin Management System:
- This system consists of a tubeless insulin pump that is worn discreetly on the body. Users can administer insulin without the limitations posed by traditional tubing systems. The system is controlled via a wireless personal diabetes manager that allows for easy insulin dose adjustments.
2. Omnipod DASH:
- The latest iteration of the Omnipod system, DASH, enhances the user experience with an intuitive design, featuring a color touchscreen interface, extended wear time, and simplified menu navigation. It facilitates better diabetes management by providing a seamless connection between the insulin pump and the user.
3. Omnipod VIEW:
- This data management software is designed to give users a clear view of their insulin delivery patterns and blood glucose levels. It helps users analyze their data, enabling more informed decision-making regarding their diabetes management strategies.
4. Omnipod DISPLAY:
- This mobile application allows users to control their Omnipod systems from their smartphones, making it easier to manage diabetes on the go. The app provides convenience and flexibility for users by enabling remote delivery adjustments.
Services
In addition to cutting-edge products, Insulet Corporation provides a suite of services aimed at supporting diabetes management and product innovation. These services include:
1. Clinical Research:
- Insulet conducts clinical trials to facilitate the development and therapeutic validation of its innovative diabetes management products. This research is crucial for ensuring the safety and efficacy of their devices.
2. Regulatory Services:
- The company offers regulatory consulting services, which assist in navigating the complex landscape of medical device regulations globally, ensuring that products meet safety standards and are compliant with regulatory requirements.
3. Manufacturing Operations:
- Insulet also offers contract manufacturing services for other medical device and drug delivery companies, leveraging its expertise in manufacturing complex medical devices and ensuring high-quality production standards.
4. Customer Support:
- Insulet is committed to providing robust customer support services, which include 24/7 availability to address inquiries and technical issues related to the Omnipod Insulin Management System. This support is essential for enhancing user experience and safety, particularly for individuals who manage diabetes daily.
In conclusion, Insulet Corporation offers a broad array of products and services tailored to meet the needs of individuals living with diabetes. By maintaining a focus on innovation, convenience, and comprehensive support, Insulet continues to strengthen its position as an industry leader in diabetes management solutions.